Delivery Order SPE2DB22D1106-SPE2DB24FDHN3
Award Date
10/16/23
Potential Completion Date
10/17/23
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,988.43 firm fixed-price delivery order is for Ropivacaine 0.2% 400 mg/200 ml injectables, with a completion date of August 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. The $5,997.77 firm-fixed price delivery order has a completion date of November 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,174.42 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 400 mg/200 ml medication, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554735557 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The firm-fixed-price delivery order, valued at $10,088.92, has a completion date of September 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) and operates as a for-profit...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.86, is for the delivery of 400 mg/200 mL of Ropivacaine 0.2% solution. It is a firm fixed-price delivery order contract with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Medical Supply Chain for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectables. The contract, identified as SPE2DX15D1053|SPE2DX24F6CZS, is a Firm Fixed Price Delivery Order with a ceiling value of $5,396.69 and a period of performance through November 27, 2023. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,883.24 firm-fixed-price delivery order is for the supply of 4565878585 - Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a period of performance through September 20, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. This delivery...
This federal contract award, with ID SPE2DX15D7056|SPE2DX24F1SPD, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,159.49 firm fixed-price delivery order is for the supply of 4562558315 - Ropivacaine 0.2% 200 mg/100 ml, 100 ml, with a performance period ending on October 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,982.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564415866 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 29, 2024 and is a Firm Fixed Price Delivery Order. The contract was awarded on April 26, 2024 and is not designated as a set-aside....
This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication, valued at $4,820.26, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...